Skip to main navigation Skip to search Skip to main content

Four-year outcomes after transcatheter or contemporary surgical sortic valve replacement from the Evolut Low Risk trial

  • Basel Ramlawi
  • , G Michael Deeb
  • , Mubashir Mumtaz
  • , Tanvir Bajwa
  • , Joshua D Rovin
  • , Steven J Yakubov
  • , Yoojin Jung
  • , Michael J Reardon
  • , John K Forrest
  • Cardiovascular Surgery, Lankenau Heart Institute, Philadelphia, PA. Electronic address: [email protected].
  • Department of Cardiothoracic Surgery, University of Michigan Hospitals, Ann Arbor, MI.
  • Department of Cardiac Surgery, University of Pittsburgh Medical Center, Harrisburg, PA.
  • Center for Advanced Valve and Structural Heart Care, Morton Plant Hospital, Clearwater, FL.
  • Department of Interventional Cardiology, Riverside Methodist-OhioHealth, Columbus, OH.
  • Structural Heart and Aortic, Medtronic, Minneapolis, MN.
  • Department of Cardiothoracic Surgery and Interventional Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX.
  • Department of Internal Medicine (Cardiology), Yale University School of Medicine, New Haven, CT.

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalJournal of Thoracic and Cardiovascular Surgery
DOIs
StatusPublished - Aug 22 2024

Keywords

  • TAVR
  • surgical valves

Cite this